Narcotic Drugs Regulation 2016
20Condition that medicinal cannabis licence holder notify the Secretary of certain matters
Start here
Get a plain-English read of 20
Turn the raw legal text into a practical explanation grounded in Narcotic Drugs Regulation 2016.
20 Condition that medicinal cannabis licence holder notify the Secretary of certain matters
(1) For the purposes of paragraph 10K(1)(d) of the Act, the following matters are prescribed in relation to a medicinal cannabis licence: (a) a security breach, a suspected security breach, an unauthorised access or a suspected unauthorised access, in relation to the location, premises or facilities covered by the licence; (b) a theft, or a suspected theft, of cannabis plants, cannabis drugs or starting materials in relation to such drugs from the location, premises or facilities covered by the licence; (c) a loss, or a suspected loss, of cannabis plants, cannabis drugs or starting materials in relation to such drugs at the location, premises or facilities covered by the licence; (d) a discrepancy, or a suspected discrepancy, in the number or quantity of cannabis plants, cannabis drugs or starting materials in relation to such drugs in the possession or under the control of the licence holder; (e) a loss, or a suspected loss, of cannabis plants, cannabis drugs or starting materials in relation to such drugs in the possession or under the control of the licence holder, other than at the location, premises or facilities covered by the licence, including during transportation of the cannabis plants, cannabis drugs or starting materials; (f) a serious incident involving cannabis plants, cannabis drugs or starting materials in relation to such drugs in the possession or under the control of the licence holder during transportation of the cannabis plants, cannabis drugs or starting materials; (g) an adverse finding or a recommendation, relating to security matters, made in a security audit report or other report relating to the location, premises or facilities covered by the licence; (h) a change made, or proposed to be made, by the licence holder in relation to premises, security arrangements, conduct of activities, record‑keeping, staff or contractors, or other arrangements relating to the licence, in response to any of the following: (i) a direction of the Secretary under section 14P of the Act; (ii) a new condition imposed on the licence under the Act; (iii) a variation of the licence or a medicinal cannabis permit that relates to the licence; (iv) a finding or a recommendation notified to the licence holder and arising from the monitoring, inspection or investigation of the activities covered by the licence; (ha) the licence holder commences to manufacture a cannabis drug under the licence; (i) the licence holder ceases to undertake, or proposes to cease undertaking, an activity authorised by the licence; (j) if the licence holder is a body corporate—a transaction that results in, or a proposed transaction that will result in, a change to the type, name or number of shares in the body corporate that are held by a person; (k) if the licence holder is a body corporate—a change, or a proposed change, in any of the directors or officers of the body corporate; (l) the licence holder has been notified that a Commonwealth, State or Territory agency has commenced to inquire into, or investigate, any actions, conduct or activities relating to the location, premises or facilities covered by the licence; (m) if the licence holder is the holder of a medicinal cannabis licence of a kind referred to in paragraph 10J(1)(a) of the Act—a contract between: (i) the licence holder; and (ii) the holder of another medicinal cannabis licence that authorises the production of cannabis or cannabis resin; is no longer in existence or is proposed to be terminated; (n) if the licence holder is the holder of a medicinal cannabis licence of a kind referred to in paragraph 10J(2)(a) of the Act—a contract between: (i) the licence holder; and (ii) the holder of another medicinal cannabis licence that authorises the manufacture of a cannabis drug; is no longer in existence or is proposed to be terminated. (2) For the purposes of paragraph 10K(2)(a) of the Act, the licence holder must notify the Secretary within the following periods: (a) for a matter covered by paragraph (1)(a), (b), (c), (d), (e) or (f) of this section—within 24 hours starting when the matter comes to the attention of the licence holder; (b) for a matter covered by paragraph (1)(g) of this section—within 20 business days starting on the day the licence holder is notified of the finding or recommendation; (c) for a matter covered by paragraph (1)(l) of this section—within 20 business days starting on the day the licence holder is notified of the inquiry or investigation.